TNF Inhibitors Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug class (Remicade, Enbrel, Humira, Cimzia, Simponi, Others); Indication (Rheumatoid Arthritis, Crohns Disease, Psoriasis, Others); Mode of Administration (Injectables, Orals, Others); Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies, others)

Report Code: TIPRE00021205 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION
:
TNF Inhibitors suppress the immune system by blocking the activity of TNF, a substance in the body that can cause inflammation and lead to immune-system diseases, such as Crohn's disease, ulcerative colitis, rheumatoid arthritis etc. TNF Inhibitors are segmented based on by Drug class, Indication, Mode of administration, distributional channel.

MARKET DYNAMICS
:
The TNF Inhibitors market is anticipated to grow in the forecast, owing to the factors such as increasing R&D, technological advancements in the equipment as well as procedures, improvements in treatment and diagnosis and low cost, increasing incidence of autoimmune diseases, and a significant rise in consumer awareness regarding TNF Inhibitors

MARKET SCOPE

The "TNF Inhibitors Market to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of TNF Inhibitors Market with detailed market segmentation by Drug class, Indication, Mode of administration, distributional channel. The TNF Inhibitors Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in TNF Inhibitors Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The TNF Inhibitors Market is segmented on the basis of Drug class, Indication, Mode of administration, distributional channel. Based on drug class Remicade, Enbrel Humira, Cimzia and Simponi., Others. Based on Indication the market is segmented as Rheumatoid, Arthritis, Crohn's disease, Psoriasis, others. Based on Mode of Administration the market is segmented as Injectable, Orals and others. Based on Distribution Channel, the market is segmented as Hospital Pharmacies, Specialty Pharmacies, and Online Pharmacies, others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the TNF Inhibitors Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The TNF Inhibitors Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting TNF Inhibitors Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the TNF Inhibitors Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the TNF Inhibitors Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from TNF Inhibitors Market are anticipated to have lucrative growth opportunities in the future with the rising demand for TNF Inhibitors Market in the global market. Below mentioned is the list of few companies engaged in the Inositol Market.

The report also includes the profiles of key players in TNF Inhibitors Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Johnson and Johnson Services, Inc
  •   Pfizer Inc.
  •   Merck and Co., Inc.
  •   Novartis AG
  •   Amgen Inc
  •   UCB S.A.
  •   AbbVie Inc
  •   Sanofi
  •   Bristol-myers squibb
  •   Shanghai Pharmaceuticals

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 TNF Inhibitors Market - By Drug class
1.3.2 TNF Inhibitors Market - By Indication
1.3.3 TNF Inhibitors Market - By Mode of Administration
1.3.4 TNF Inhibitors Market - By Distribution Channel
1.3.5 TNF Inhibitors Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TNF INHIBITORS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TNF INHIBITORS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TNF INHIBITORS MARKET - GLOBAL MARKET ANALYSIS
6.1. TNF INHIBITORS - GLOBAL MARKET OVERVIEW
6.2. TNF INHIBITORS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. TNF INHIBITORS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. REMICADE
7.3.1. Overview
7.3.2. Remicade Market Forecast and Analysis
7.4. ENBREL
7.4.1. Overview
7.4.2. Enbrel Market Forecast and Analysis
7.5. HUMIRA
7.5.1. Overview
7.5.2. Humira Market Forecast and Analysis
7.6. CIMZIA
7.6.1. Overview
7.6.2. Cimzia Market Forecast and Analysis
7.7. SIMPONI
7.7.1. Overview
7.7.2. Simponi Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. TNF INHIBITORS MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. RHEUMATOID ARTHRITIS
8.3.1. Overview
8.3.2. Rheumatoid Arthritis Market Forecast and Analysis
8.4. CROHN'S DISEASE
8.4.1. Overview
8.4.2. Crohn's Disease Market Forecast and Analysis
8.5. PSORIASIS
8.5.1. Overview
8.5.2. Psoriasis Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. TNF INHIBITORS MARKET - REVENUE AND FORECASTS TO 2028 - MODE OF ADMINISTRATION
9.1. OVERVIEW
9.2. MODE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. INJECTABLES
9.3.1. Overview
9.3.2. Injectables Market Forecast and Analysis
9.4. ORALS
9.4.1. Overview
9.4.2. Orals Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. TNF INHIBITORS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL PHARMACIES
10.3.1. Overview
10.3.2. Hospital Pharmacies Market Forecast and Analysis
10.4. SPECIALTY PHARMACIES
10.4.1. Overview
10.4.2. Specialty Pharmacies Market Forecast and Analysis
10.5. ONLINE PHARMACIES
10.5.1. Overview
10.5.2. Online Pharmacies Market Forecast and Analysis
10.6. OTHERS
10.6.1. Overview
10.6.2. others Market Forecast and Analysis
11. TNF INHIBITORS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America TNF Inhibitors Market Overview
11.1.2 North America TNF Inhibitors Market Forecasts and Analysis
11.1.3 North America TNF Inhibitors Market Forecasts and Analysis - By Drug class
11.1.4 North America TNF Inhibitors Market Forecasts and Analysis - By Indication
11.1.5 North America TNF Inhibitors Market Forecasts and Analysis - By Mode of Administration
11.1.6 North America TNF Inhibitors Market Forecasts and Analysis - By Distribution Channel
11.1.7 North America TNF Inhibitors Market Forecasts and Analysis - By Countries
11.1.7.1 United States TNF Inhibitors Market
11.1.7.1.1 United States TNF Inhibitors Market by Drug class
11.1.7.1.2 United States TNF Inhibitors Market by Indication
11.1.7.1.3 United States TNF Inhibitors Market by Mode of Administration
11.1.7.1.4 United States TNF Inhibitors Market by Distribution Channel
11.1.7.2 Canada TNF Inhibitors Market
11.1.7.2.1 Canada TNF Inhibitors Market by Drug class
11.1.7.2.2 Canada TNF Inhibitors Market by Indication
11.1.7.2.3 Canada TNF Inhibitors Market by Mode of Administration
11.1.7.2.4 Canada TNF Inhibitors Market by Distribution Channel
11.1.7.3 Mexico TNF Inhibitors Market
11.1.7.3.1 Mexico TNF Inhibitors Market by Drug class
11.1.7.3.2 Mexico TNF Inhibitors Market by Indication
11.1.7.3.3 Mexico TNF Inhibitors Market by Mode of Administration
11.1.7.3.4 Mexico TNF Inhibitors Market by Distribution Channel
11.2. EUROPE
11.2.1 Europe TNF Inhibitors Market Overview
11.2.2 Europe TNF Inhibitors Market Forecasts and Analysis
11.2.3 Europe TNF Inhibitors Market Forecasts and Analysis - By Drug class
11.2.4 Europe TNF Inhibitors Market Forecasts and Analysis - By Indication
11.2.5 Europe TNF Inhibitors Market Forecasts and Analysis - By Mode of Administration
11.2.6 Europe TNF Inhibitors Market Forecasts and Analysis - By Distribution Channel
11.2.7 Europe TNF Inhibitors Market Forecasts and Analysis - By Countries
11.2.7.1 Germany TNF Inhibitors Market
11.2.7.1.1 Germany TNF Inhibitors Market by Drug class
11.2.7.1.2 Germany TNF Inhibitors Market by Indication
11.2.7.1.3 Germany TNF Inhibitors Market by Mode of Administration
11.2.7.1.4 Germany TNF Inhibitors Market by Distribution Channel
11.2.7.2 France TNF Inhibitors Market
11.2.7.2.1 France TNF Inhibitors Market by Drug class
11.2.7.2.2 France TNF Inhibitors Market by Indication
11.2.7.2.3 France TNF Inhibitors Market by Mode of Administration
11.2.7.2.4 France TNF Inhibitors Market by Distribution Channel
11.2.7.3 Italy TNF Inhibitors Market
11.2.7.3.1 Italy TNF Inhibitors Market by Drug class
11.2.7.3.2 Italy TNF Inhibitors Market by Indication
11.2.7.3.3 Italy TNF Inhibitors Market by Mode of Administration
11.2.7.3.4 Italy TNF Inhibitors Market by Distribution Channel
11.2.7.4 Spain TNF Inhibitors Market
11.2.7.4.1 Spain TNF Inhibitors Market by Drug class
11.2.7.4.2 Spain TNF Inhibitors Market by Indication
11.2.7.4.3 Spain TNF Inhibitors Market by Mode of Administration
11.2.7.4.4 Spain TNF Inhibitors Market by Distribution Channel
11.2.7.5 United Kingdom TNF Inhibitors Market
11.2.7.5.1 United Kingdom TNF Inhibitors Market by Drug class
11.2.7.5.2 United Kingdom TNF Inhibitors Market by Indication
11.2.7.5.3 United Kingdom TNF Inhibitors Market by Mode of Administration
11.2.7.5.4 United Kingdom TNF Inhibitors Market by Distribution Channel
11.2.7.6 Rest of Europe TNF Inhibitors Market
11.2.7.6.1 Rest of Europe TNF Inhibitors Market by Drug class
11.2.7.6.2 Rest of Europe TNF Inhibitors Market by Indication
11.2.7.6.3 Rest of Europe TNF Inhibitors Market by Mode of Administration
11.2.7.6.4 Rest of Europe TNF Inhibitors Market by Distribution Channel
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific TNF Inhibitors Market Overview
11.3.2 Asia-Pacific TNF Inhibitors Market Forecasts and Analysis
11.3.3 Asia-Pacific TNF Inhibitors Market Forecasts and Analysis - By Drug class
11.3.4 Asia-Pacific TNF Inhibitors Market Forecasts and Analysis - By Indication
11.3.5 Asia-Pacific TNF Inhibitors Market Forecasts and Analysis - By Mode of Administration
11.3.6 Asia-Pacific TNF Inhibitors Market Forecasts and Analysis - By Distribution Channel
11.3.7 Asia-Pacific TNF Inhibitors Market Forecasts and Analysis - By Countries
11.3.7.1 Australia TNF Inhibitors Market
11.3.7.1.1 Australia TNF Inhibitors Market by Drug class
11.3.7.1.2 Australia TNF Inhibitors Market by Indication
11.3.7.1.3 Australia TNF Inhibitors Market by Mode of Administration
11.3.7.1.4 Australia TNF Inhibitors Market by Distribution Channel
11.3.7.2 China TNF Inhibitors Market
11.3.7.2.1 China TNF Inhibitors Market by Drug class
11.3.7.2.2 China TNF Inhibitors Market by Indication
11.3.7.2.3 China TNF Inhibitors Market by Mode of Administration
11.3.7.2.4 China TNF Inhibitors Market by Distribution Channel
11.3.7.3 India TNF Inhibitors Market
11.3.7.3.1 India TNF Inhibitors Market by Drug class
11.3.7.3.2 India TNF Inhibitors Market by Indication
11.3.7.3.3 India TNF Inhibitors Market by Mode of Administration
11.3.7.3.4 India TNF Inhibitors Market by Distribution Channel
11.3.7.4 Japan TNF Inhibitors Market
11.3.7.4.1 Japan TNF Inhibitors Market by Drug class
11.3.7.4.2 Japan TNF Inhibitors Market by Indication
11.3.7.4.3 Japan TNF Inhibitors Market by Mode of Administration
11.3.7.4.4 Japan TNF Inhibitors Market by Distribution Channel
11.3.7.5 South Korea TNF Inhibitors Market
11.3.7.5.1 South Korea TNF Inhibitors Market by Drug class
11.3.7.5.2 South Korea TNF Inhibitors Market by Indication
11.3.7.5.3 South Korea TNF Inhibitors Market by Mode of Administration
11.3.7.5.4 South Korea TNF Inhibitors Market by Distribution Channel
11.3.7.6 Rest of Asia-Pacific TNF Inhibitors Market
11.3.7.6.1 Rest of Asia-Pacific TNF Inhibitors Market by Drug class
11.3.7.6.2 Rest of Asia-Pacific TNF Inhibitors Market by Indication
11.3.7.6.3 Rest of Asia-Pacific TNF Inhibitors Market by Mode of Administration
11.3.7.6.4 Rest of Asia-Pacific TNF Inhibitors Market by Distribution Channel
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa TNF Inhibitors Market Overview
11.4.2 Middle East and Africa TNF Inhibitors Market Forecasts and Analysis
11.4.3 Middle East and Africa TNF Inhibitors Market Forecasts and Analysis - By Drug class
11.4.4 Middle East and Africa TNF Inhibitors Market Forecasts and Analysis - By Indication
11.4.5 Middle East and Africa TNF Inhibitors Market Forecasts and Analysis - By Mode of Administration
11.4.6 Middle East and Africa TNF Inhibitors Market Forecasts and Analysis - By Distribution Channel
11.4.7 Middle East and Africa TNF Inhibitors Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa TNF Inhibitors Market
11.4.7.1.1 South Africa TNF Inhibitors Market by Drug class
11.4.7.1.2 South Africa TNF Inhibitors Market by Indication
11.4.7.1.3 South Africa TNF Inhibitors Market by Mode of Administration
11.4.7.1.4 South Africa TNF Inhibitors Market by Distribution Channel
11.4.7.2 Saudi Arabia TNF Inhibitors Market
11.4.7.2.1 Saudi Arabia TNF Inhibitors Market by Drug class
11.4.7.2.2 Saudi Arabia TNF Inhibitors Market by Indication
11.4.7.2.3 Saudi Arabia TNF Inhibitors Market by Mode of Administration
11.4.7.2.4 Saudi Arabia TNF Inhibitors Market by Distribution Channel
11.4.7.3 U.A.E TNF Inhibitors Market
11.4.7.3.1 U.A.E TNF Inhibitors Market by Drug class
11.4.7.3.2 U.A.E TNF Inhibitors Market by Indication
11.4.7.3.3 U.A.E TNF Inhibitors Market by Mode of Administration
11.4.7.3.4 U.A.E TNF Inhibitors Market by Distribution Channel
11.4.7.4 Rest of Middle East and Africa TNF Inhibitors Market
11.4.7.4.1 Rest of Middle East and Africa TNF Inhibitors Market by Drug class
11.4.7.4.2 Rest of Middle East and Africa TNF Inhibitors Market by Indication
11.4.7.4.3 Rest of Middle East and Africa TNF Inhibitors Market by Mode of Administration
11.4.7.4.4 Rest of Middle East and Africa TNF Inhibitors Market by Distribution Channel
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America TNF Inhibitors Market Overview
11.5.2 South and Central America TNF Inhibitors Market Forecasts and Analysis
11.5.3 South and Central America TNF Inhibitors Market Forecasts and Analysis - By Drug class
11.5.4 South and Central America TNF Inhibitors Market Forecasts and Analysis - By Indication
11.5.5 South and Central America TNF Inhibitors Market Forecasts and Analysis - By Mode of Administration
11.5.6 South and Central America TNF Inhibitors Market Forecasts and Analysis - By Distribution Channel
11.5.7 South and Central America TNF Inhibitors Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil TNF Inhibitors Market
11.5.7.1.1 Brazil TNF Inhibitors Market by Drug class
11.5.7.1.2 Brazil TNF Inhibitors Market by Indication
11.5.7.1.3 Brazil TNF Inhibitors Market by Mode of Administration
11.5.7.1.4 Brazil TNF Inhibitors Market by Distribution Channel
11.5.7.2 Argentina TNF Inhibitors Market
11.5.7.2.1 Argentina TNF Inhibitors Market by Drug class
11.5.7.2.2 Argentina TNF Inhibitors Market by Indication
11.5.7.2.3 Argentina TNF Inhibitors Market by Mode of Administration
11.5.7.2.4 Argentina TNF Inhibitors Market by Distribution Channel
11.5.7.3 Rest of South and Central America TNF Inhibitors Market
11.5.7.3.1 Rest of South and Central America TNF Inhibitors Market by Drug class
11.5.7.3.2 Rest of South and Central America TNF Inhibitors Market by Indication
11.5.7.3.3 Rest of South and Central America TNF Inhibitors Market by Mode of Administration
11.5.7.3.4 Rest of South and Central America TNF Inhibitors Market by Distribution Channel
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL TNF INHIBITORS MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. TNF INHIBITORS MARKET, KEY COMPANY PROFILES
14.1. JOHNSON AND JOHNSON SERVICES, INC
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. PFIZER INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. MERCK AND CO., INC.
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. NOVARTIS AG
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. AMGEN INC
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. UCB S.A.
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. ABBVIE INC
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. SANOFI
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. BRISTOL-MYERS SQUIBB
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. SHANGHAI PHARMACEUTICALS
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Johnson and Johnson Services, Inc
2. Pfizer Inc.
3. Merck and Co., Inc.
4. Novartis AG
5. Amgen Inc
6. UCB S.A.
7. AbbVie Inc
8. Sanofi
9. Bristol-myers squibb
10. Shanghai Pharmaceuticals
11. HanAll Biopharma
12. Intas Pharmaceuticals
13. LEO Pharma
14. LG Life Sciences
15. MedImmune
TIPRE00021205
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking